IP Library › Granted Patent US 8,114,095
Granted Patent B2
US 8,114,095 · App. 11/595,739 · Granted Feb 14, 2012

Intraocular lens injection apparatus and method

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,114,095
App. No.
11/595,739
Granted
Feb 14, 2012
Kind
B2
Abstract

An IOL injector comprising a distal body portion comprising a tip through which an IOL is injected into an eye, a tip protector, and a proximal body portion configured to connect to the distal body portion. The distal body portion and the tip protector being are configured to lockingly connect together, and the tip protector and proximal body portion are configured to interact with one another such that, when the tip protector and the distal body portion are in a connected state, the tip protector is unlocked from the distal body portion as the proximal body portion is being connected to the distal body portion.

Claims (12)

1. An IOL injector kit, comprising:

a distal body portion having a longitudinal axis and a length in the direction of the longitudinal axis, the distal body portion comprising a tip configured to permit an IOL to be injected therethrough into an eye;

a tip protector, the distal body portion and the tip protector being configured to lockingly connect together, the tip protector extending along only a portion of the length of the distal body portion; and

a proximal body portion configured to connect to the distal body portion, the tip protector and proximal body portion being configured to interact with one another such that, when the tip protector and the distal body portion are in a connected state, the tip protector is caused to be unlocked from the distal body portion by the proximal body portion as the proximal body portion is being connected to the distal body portion.

2. The kit of claim 1 , wherein the distal body portion comprises a flange and the tip protector comprises at least one latch, the latch and flange being configured to lockingly connect the distal body portion and the tip protector together.

3. The kit of claim 1 , wherein the tip protector comprises a side wall configured to enclose the tip.

4. The kit of claim 1 , wherein the tip protector and the distal body portion are lockingly connected together.

5. A method of preparing an IOL injector kit of claim 1 for insertion of an IOL, comprising:

unlocking a tip protector from a distal body portion by connecting a proximal body portion to the distal body portion.

6. The method of claim 5 , further comprising lockingly connecting a tip holder to a distal body portion, prior to the step of unlocking.

7. The method of claim 5 , further comprising a step of loading the injector with an IOL prior to the step of unlocking the tip holder from the distal body portion.

8. The method of claim 5 , further comprising a step of loading the injector with an IOL after the step of unlocking the tip holder from the distal body portion.

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD; SANTARUS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; HUMAX PHARMACEUTICAL S.A.; SOLTA MEDICAL IRELAND LIMITED; BAUSCH & LOMB MEXICO, S.A. DE C.V.; BAUSCH+LOMB OPS B.V.; BAUSCH HEALTH AMERICAS, INC.; BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH HOLDCO LIMITED; BAUSCH HEALTH MAGYARORSZAG KFT (A/K/A BAUSCH HEALTH HUNGARY LLC); BAUSCH HEALTH POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA (F/K/A VALEANT PHARMA POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA); BAUSCH HEALTH US, LLC; BAUSCH HEALTH, CANADA INC. / SANTE BAUSCH, CANADA INC.; ICN POLFA RZESZOW SPOLKA AKCYJNA (A/K/A ICN POLFA RZESZOW S.A.); ORAPHARMA, INC.; PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA SPOLKA AKCYJNA (A/K/A PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA S.A.); SOLTA MEDICAL DUTCH HOLDINGS B.V.; V-BAC HOLDING CORP.; VRX HOLDCO LLC; 1261229 B.C. LTD.; 1530065 B.C. LTD.
Reel/Frame 070778/0199 →
NOTICE OF SUCCESSION OF AGENCY Recorded Jan 9, 2015
From: GOLDMAN SACHS LENDING PARTNERS, LLC
To: BARCLAYS BANK PLC, AS SUCCESSOR AGENT
Reel/Frame 034749/0689 →
SECURITY AGREEMENT Recorded Sep 4, 2013
From: BAUSCH & LOMB INCORPORATED
To: GOLDMAN SACHS LENDING PARTNERS LLC, AS COLLATERAL AGENT
Reel/Frame 031156/0508 →
RELEASE OF SECURITY INTEREST Recorded Aug 13, 2013
From: CITIBANK N.A., AS ADMINISTRATIVE AGENT
To: WP PRISM INC. (N/K/A BAUSCH & LOMB HOLDINGS INC.); BAUSCH & LOMB INCORPORATED; ISTA PHARMACEUTICALS
Reel/Frame 030995/0444 →
SECURITY AGREEMENT Recorded Aug 6, 2012
From: BAUSCH & LOMB INCORPORATED; EYEONICS, INC.
To: CITIBANK N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 028728/0645 →
RELEASE OF SECURITY INTEREST Recorded Aug 5, 2012
From: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH
To: BAUSCH & LOMB INCORPORATED
Reel/Frame 028726/0142 →
SECURITY AGREEMENT Recorded Apr 23, 2012
From: BAUSCH & LOMB INCORPORATED
To: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH
Reel/Frame 028090/0019 →